Encompass Health CEO reports tax share withholding

Encompass Health Corp President and CEO Mark J. Tarr reported a tax-related share disposition.

Rhea-AI Filing Summary

Encompass Health Corp President and CEO Mark J. Tarr reported a tax-related share disposition. On the transaction date, 2,488 shares of Encompass Health common stock were withheld at $106.15 per share to cover his tax withholding obligations from vesting restricted stock. After this withholding disposition, Tarr directly owned 443,149 shares of Encompass Health common stock, reflecting his ongoing equity stake in the company.

Insider Trade Summary

Exercise Price or Tax Liability: 2,488 shares

Exercise Price or Tax Liability 1 txn

Insider Tarr Mark J

Role President & CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	2,488	$106.15	$264K

Holdings After Transaction: Encompass Health Common Stock — 443,149 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

What did Encompass Health (EHC) CEO Mark Tarr report in this Form 4?

Mark Tarr reported a tax-withholding share disposition, where 2,488 Encompass Health common shares were withheld at $106.15 each. These shares covered taxes from vesting restricted stock, and were not an open-market sale of his holdings.

How many Encompass Health (EHC) shares were involved in Mark Tarr’s tax withholding?

The Form 4 shows 2,488 Encompass Health common shares were withheld at $106.15 per share. This withholding satisfied Mark Tarr’s tax obligations arising from the vesting of related restricted stock awards.

Did Encompass Health (EHC) CEO Mark Tarr sell shares in the open market?

No, the transaction is classified as a tax-withholding disposition under code F. Shares were withheld or surrendered to cover tax obligations from vesting restricted stock, rather than being sold in an open-market transaction.

How many Encompass Health (EHC) shares does Mark Tarr own after this filing?

After the tax-withholding disposition, Mark Tarr directly owned 443,149 Encompass Health common shares. This figure reflects his remaining equity stake following the 2,488 shares withheld to satisfy restricted stock tax obligations.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F indicates payment of an exercise price or tax liability by delivering securities. In this case, 2,488 Encompass Health shares were withheld to cover Mark Tarr’s tax obligations from vesting restricted stock, rather than being sold for investment purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 09:33 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarr Mark J

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		2,488(1)	D	$106.15	443,149	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Mark J. Tarr	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.